Literature DB >> 2369370

Dose- and shear rate-dependent effects of heparin on thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood.

W Inauen1, H R Baumgartner, T Bombeli, A Haeberli, P W Straub.   

Abstract

The effect of heparin on thrombogenesis induced by the subendothelium of rabbit aorta was investigated in 24 healthy volunteers after intravenous injection of different doses (0, 1000, 2500, and 5000 IU). By using an ex vivo perfusion chamber system, the interaction between flowing blood and exposed subendothelium was measured at low (50 s-1), intermediate (650 s-1), and high (2600 s-1) wall shear rates. The low shear rate simulated blood flow in venous, the intermediate shear rate in arterial, and the high shear rate in small or stenosed arterial vessels. Deposition of fibrin, platelets, and platelet thrombi on vascular subendothelium (SE) was quantified by morphometrical and immunological techniques. Fibrin deposition prevailed at low shear rates and was only minimal at high shear rates (30 +/- 1% vs. 1 +/- 0.4% coverage of SE with fibrin, means +/- SEM, p less than 0.001). In contrast, the interaction of platelets with SE was more intense at high compared to low shear rates, as indicated by higher platelet adhesion (54 +/- 5% vs. 4 +/- 1% coverage of SE with platelets, p less than 0.001) and platelet thrombus volumes (4.8 +/- 1.3 vs. 0.5 +/- 0.1 microns 3/microns 2, p less than 0.001). Fibrin deposition on SE was inhibited by heparin in a dose-dependent manner and was abolished after high doses. In addition, high doses of heparin reduced the height and volume of platelet thrombi at low and intermediate wall shear rates, but no effect was found at the high shear rate. Our data show that heparin inhibits the formation of both fibrin and platelet thrombi on vascular subendothelium. The lack of effect of heparin on platelet thrombus formation at high shear rates indicates that thrombin modulates the growth rate and/or stability of platelet thrombi at low and intermediate shear rates, whereas additional factors may control platelet thrombus growth and stability at high shear conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369370     DOI: 10.1161/01.atv.10.4.607

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  11 in total

1.  A novel ovine ex vivo arteriovenous shunt model to test vascular implantability.

Authors:  Haofan Peng; Evan M Schlaich; Sindhu Row; Stelios T Andreadis; Daniel D Swartz
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

2.  Evaluation of the effect of 6 von Willebrand factor concentrates on platelet adhesion to human vein segments under flow conditions.

Authors:  Wolfgang Mouton; Jerzy Madon; Joerg Fehr; Thomas Bombeli
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

3.  Development of zwitterionic sulfobetaine block copolymer conjugation strategies for reduced platelet deposition in respiratory assist devices.

Authors:  Alexander D Malkin; Sang-Ho Ye; Evan J Lee; Xiguang Yang; Yang Zhu; Lara J Gamble; William J Federspiel; William R Wagner
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-02-09       Impact factor: 3.368

Review 4.  Shear-dependence of endothelial functions.

Authors:  W H Reinhart
Journal:  Experientia       Date:  1994-02-15

5.  Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.

Authors:  D Kirchhofer; T B Tschopp; P Hadváry; H R Baumgartner
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Authors:  Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

7.  Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.

Authors:  Vishal Trivedi; Adrienne Boire; Boris Tchernychev; Nicole C Kaneider; Andrew J Leger; Katie O'Callaghan; Lidija Covic; Athan Kuliopulos
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

Review 8.  Matrix metalloproteases and PAR1 activation.

Authors:  Karyn M Austin; Lidija Covic; Athan Kuliopulos
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

9.  Role of sodium tungstate as a potential antiplatelet agent.

Authors:  Rebeca Fernández-Ruiz; Marc Pino; Begoña Hurtado; Pablo García de Frutos; Carolina Caballo; Ginés Escolar; Ramón Gomis; Maribel Diaz-Ricart
Journal:  Drug Des Devel Ther       Date:  2015-05-26       Impact factor: 4.162

Review 10.  Bactericidal efficiency of micro- and nanostructured surfaces: a critical perspective.

Authors:  S W M A I Senevirathne; J Hasan; A Mathew; M Woodruff; P K D V Yarlagadda
Journal:  RSC Adv       Date:  2021-01-13       Impact factor: 3.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.